Catheter Precision Raises $2.821M via Series C-4 Preferred Stock Sale

Catheter Precision, Inc. completed the sale of 2,821 shares of its Series C-4 Convertible Preferred Stock, raising $2.821 million in gross proceeds. The preferred stock was issued to accredited investors exercising their Additional Investment Right. The company intends to use the net proceeds for working capital, general corporate purposes, and the redemption of all outstanding Series B Convertible Preferred Stock. The Series C-4 Preferred Stock ranks senior to common stock, and its conversion will result in dilution for existing common shareholders.